Qingxia Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qingxia Yang has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Feng Zhu
Zhejiang University
9 shared publications - Minjie Mou
College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou 310058
4 shared publications - Huaicheng Sun
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
3 shared publications Yaguo Gong
School of Pharmacy, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao 999078, China
3 shared publications- Yaguo Gong
School of Pharmacy, Macau University of Science and Technology, Macau, China
3 shared publications Yuan Zhou
School of Pharmacy, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou 310058
3 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
scSpatial: an atlas for single-cell spatial omics
Single-cell spatial omics (SCSO) has reshaped spatial profiling by enabling simultaneous molecular characterization and spatial mapping at single-cell resolution, providing insights into cellular identities and tissue architecture within native biological contexts. By integrating spatial coordinates with molecular profiles and cell identities, SCSO datasets have been widely used to construct spatially resolved cell atlases, characterize disease-associated tissue remodeling, and map disease-relevant cell populations. However, these SCSO datasets remain fragmented across individual publications, and comprehensive SCSO resources are still lacking. Here, scSpatial was therefore developed as an atlas for SCSO with expert-curated cell annotations and high-resolution spatial mappings. The current release of scSpatial curates a large-scale collection of SCSO data, comprising over 1800 tissue sections from 630 projects generated using 16 spatial technologies; provides >20 million spatially resolved cells annotated into 173 standardized Cell Ontology types; and offers SCSO-tailored analyses and interactive visualizations, including spatial gene expression atlases, cell type distribution maps, spatially variable genes, gene expression correlations, and pathway-level spatial activity profiles. scSpatial is freely accessible to all users without requiring login at https://idrblab.org/scspatial/.
- 23 October 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
Open AccessscSpatial: an atlas for single-cell spatial omics
Single-cell spatial omics (SCSO) has reshaped spatial profiling by enabling simultaneous molecular characterization and spatial mapping at single-cell resolution, providing insights into cellular identities and tissue architecture within native biological contexts. By integrating spatial coordinates with molecular profiles and cell identities, SCSO datasets have been widely used to construct spatially resolved cell atlases, characterize disease-associated tissue remodeling, and map disease-relevant cell populations. However, these SCSO datasets remain fragmented across individual publications, and comprehensive SCSO resources are still lacking. Here, scSpatial was therefore developed as an atlas for SCSO with expert-curated cell annotations and high-resolution spatial mappings. The current release of scSpatial curates a large-scale collection of SCSO data, comprising over 1800 tissue sections from 630 projects generated using 16 spatial technologies; provides >20 million spatially resolved cells annotated into 173 standardized Cell Ontology types; and offers SCSO-tailored analyses and interactive visualizations, including spatial gene expression atlases, cell type distribution maps, spatially variable genes, gene expression correlations, and pathway-level spatial activity profiles. scSpatial is freely accessible to all users without requiring login at https://idrblab.org/scspatial/.
- Open Access
- 30 September 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
SingPro 2.0: a proteomics-centric knowledge base for single-cell multimodal profiling
Protein-inclusive single-cell multimodal profiling has emerged as a transformative strategy for resolving cellular heterogeneity by jointly measuring proteins and complementary molecular features in the same cells. The resulting protein-inclusive datasets are increasingly used to characterize cellular states, construct multimodal cell atlases, and decode disease mechanisms. However, such data are rarely included in existing databases. In this study, SingPro was updated from a single-cell proteomics database into a proteomics-centric knowledge base for single-cell multimodal profiling. Distinct from existing resources, the updated SingPro (a) systematically curates data and experimental details from 814 protein-inclusive multimodal studies encompassing ~81.5 million cells across 29 tissues, 44 diseases, and multiple species; (b) covers 5 omics modalities through 12 experimental technologies that simultaneously profile proteins with messenger RNA, chromatin accessibility, or other measurements in the same cell; and (c) provides cross-modality visualization for joint analysis. SingPro is freely accessible without requiring login or registration at: https://idrblab.org/singpro/.
- 30 September 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
Open AccessSingPro 2.0: a proteomics-centric knowledge base for single-cell multimodal profiling
Protein-inclusive single-cell multimodal profiling has emerged as a transformative strategy for resolving cellular heterogeneity by jointly measuring proteins and complementary molecular features in the same cells. The resulting protein-inclusive datasets are increasingly used to characterize cellular states, construct multimodal cell atlases, and decode disease mechanisms. However, such data are rarely included in existing databases. In this study, SingPro was updated from a single-cell proteomics database into a proteomics-centric knowledge base for single-cell multimodal profiling. Distinct from existing resources, the updated SingPro (a) systematically curates data and experimental details from 814 protein-inclusive multimodal studies encompassing ~81.5 million cells across 29 tissues, 44 diseases, and multiple species; (b) covers 5 omics modalities through 12 experimental technologies that simultaneously profile proteins with messenger RNA, chromatin accessibility, or other measurements in the same cell; and (c) provides cross-modality visualization for joint analysis. SingPro is freely accessible without requiring login or registration at: https://idrblab.org/singpro/.
- Open Access
- 1 May 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (W1) , W390-W397
MMEASE: enhanced analytical workflow for single-cell metabolomics
Metabolomics is essential for providing an overview of what chemical processes are taking place. A clear shift from bulk metabolomics to single-cell metabolomics (SCM) is observed in current research, and an integral workflow enabling the analysis of SCM data is therefore in great demand. However, no such workflow has been available to date. Herein, MMEASE, previously designed for analyzing bulk metabolomic data, was therefore updated to its 2.0 version by developing the first comprehensive and in-depth workflow analyzing SCM data. First, it provided all sequential steps of modern SCM research (from SCM data processing, to cellular heterogeneity analysis, then to high-resolution metabolite annotation, and finally to cell-based biological interpretation). Second, compared with the existing tools, MMEASE 2.0 was superior by incorporating the widest variety of methods at every step of the SCM analyses. The originality and functionality of our MMEASE were extensively validated and explicitly described by case studies on benchmark data. All in all, MMEASE 2.0 was unique in accomplishing comprehensive and in-depth analyses of SCM data, which could be considered as an indispensable complement to the existing tools. Now, the latest version of MMEASE is freely accessible by all users at: https://idrblab.org/mmease/
- 1 May 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (W1) , W390-W397
Open AccessMMEASE: enhanced analytical workflow for single-cell metabolomics
Metabolomics is essential for providing an overview of what chemical processes are taking place. A clear shift from bulk metabolomics to single-cell metabolomics (SCM) is observed in current research, and an integral workflow enabling the analysis of SCM data is therefore in great demand. However, no such workflow has been available to date. Herein, MMEASE, previously designed for analyzing bulk metabolomic data, was therefore updated to its 2.0 version by developing the first comprehensive and in-depth workflow analyzing SCM data. First, it provided all sequential steps of modern SCM research (from SCM data processing, to cellular heterogeneity analysis, then to high-resolution metabolite annotation, and finally to cell-based biological interpretation). Second, compared with the existing tools, MMEASE 2.0 was superior by incorporating the widest variety of methods at every step of the SCM analyses. The originality and functionality of our MMEASE were extensively validated and explicitly described by case studies on benchmark data. All in all, MMEASE 2.0 was unique in accomplishing comprehensive and in-depth analyses of SCM data, which could be considered as an indispensable complement to the existing tools. Now, the latest version of MMEASE is freely accessible by all users at: https://idrblab.org/mmease/
- 6 January 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (2) , 1254-1263
Benchmark of Data Integration in Single-Cell Proteomics
Single-cell proteomics (SCP) detected based on different technologies always involves batch-specific variations because of differences in sample processing and other potential biases. How to integrate SCP data effectively has become a great challenge. Integration of SCP data not only requires the conservation of true biological variances, but also realizes the removal of unwanted batch effects. In this study, benchmarking analysis of popular data integration methods was conducted to determine the most suitable method for SCP data. To comprehensively evaluate the performance of these integration methods, a novel evaluation system was proposed for integrating SCP data. This evaluation system consists of three objective measures from different perspectives: category (a), the efficacy of correcting batch effects; category (b), the power of conserving biological variances; and category (c), the ability to identify consistent markers. For this comprehensive evaluation, five benchmark data sets under different scenarios (containing substantial proteins, substantial cells, multiple batches, multiple cell types, and unbalanced data) were utilized for selecting the most suitable data integration method. As a result, three methods, ComBat, Scanorama, and Seurat version 3 CCA, were identified as the most recommended methods for integrating SCP data. Overall, this systematic evaluation might provide valuable guidance in choosing the appropriate method for data integration in the SCP.
- 6 January 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (2) , 1254-1263
Benchmark of Data Integration in Single-Cell Proteomics
Single-cell proteomics (SCP) detected based on different technologies always involves batch-specific variations because of differences in sample processing and other potential biases. How to integrate SCP data effectively has become a great challenge. Integration of SCP data not only requires the conservation of true biological variances, but also realizes the removal of unwanted batch effects. In this study, benchmarking analysis of popular data integration methods was conducted to determine the most suitable method for SCP data. To comprehensively evaluate the performance of these integration methods, a novel evaluation system was proposed for integrating SCP data. This evaluation system consists of three objective measures from different perspectives: category (a), the efficacy of correcting batch effects; category (b), the power of conserving biological variances; and category (c), the ability to identify consistent markers. For this comprehensive evaluation, five benchmark data sets under different scenarios (containing substantial proteins, substantial cells, multiple batches, multiple cell types, and unbalanced data) were utilized for selecting the most suitable data integration method. As a result, three methods, ComBat, Scanorama, and Seurat version 3 CCA, were identified as the most recommended methods for integrating SCP data. Overall, this systematic evaluation might provide valuable guidance in choosing the appropriate method for data integration in the SCP.
- Open Access
- 22 October 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (D1) , D1651-D1662
Chem(Pro)2: the atlas of chemoproteomic probes labelling human proteins
Chemoproteomic probes (CPPs) have been widely considered as powerful molecular biological tools that enable the highly efficient discovery of both binding proteins and modes of action for the studied compounds. They have been successfully used to validate targets and identify binders. The design of CPP has been considered extremely challenging, which asks for the generalization using a large number of probe data. However, none of the existing databases gives such valuable data of CPPs. Herein, a database entitled ‘Chem(Pro)2’ was therefore developed to systematically describe the atlas of diverse types of CPPs labelling human protein in living cell/lysate. With the booming application of chemoproteomic technique and artificial intelligence in current chemical biology study, Chem(Pro)2 was expected to facilitate the AI-based learning of interacting pattern among molecules for discovering innovative targets and new drugs. Till now, Chem(Pro)2 has been open to all users without any login requirement at: https://idrblab.org/chemprosquare/
- 22 October 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (D1) , D1651-D1662
Open AccessChem(Pro)2: the atlas of chemoproteomic probes labelling human proteins
Chemoproteomic probes (CPPs) have been widely considered as powerful molecular biological tools that enable the highly efficient discovery of both binding proteins and modes of action for the studied compounds. They have been successfully used to validate targets and identify binders. The design of CPP has been considered extremely challenging, which asks for the generalization using a large number of probe data. However, none of the existing databases gives such valuable data of CPPs. Herein, a database entitled ‘Chem(Pro)2’ was therefore developed to systematically describe the atlas of diverse types of CPPs labelling human protein in living cell/lysate. With the booming application of chemoproteomic technique and artificial intelligence in current chemical biology study, Chem(Pro)2 was expected to facilitate the AI-based learning of interacting pattern among molecules for discovering innovative targets and new drugs. Till now, Chem(Pro)2 has been open to all users without any login requirement at: https://idrblab.org/chemprosquare/
- 28 February 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (12) , 4745-4755
Strategy for Identifying a Robust Metabolomic Signature Reveals the Altered Lipid Metabolism in Pituitary Adenoma
Despite the well-established connection between systematic metabolic abnormalities and the pathophysiology of pituitary adenoma (PA), current metabolomic studies have reported an extremely limited number of metabolites associated with PA. Moreover, there was very little consistency in the identified metabolite signatures, resulting in a lack of robust metabolic biomarkers for the diagnosis and treatment of PA. Herein, we performed a global untargeted plasma metabolomic profiling on PA and identified a highly robust metabolomic signature based on a strategy. Specifically, this strategy is unique in (1) integrating repeated random sampling and a consensus evaluation-based feature selection algorithm and (2) evaluating the consistency of metabolomic signatures among different sample groups. This strategy demonstrated superior robustness and stronger discriminative ability compared with that of other feature selection methods including Student's t-test, partial least-squares-discriminant analysis, support vector machine recursive feature elimination, and random forest recursive feature elimination. More importantly, a highly robust metabolomic signature comprising 45 PA-specific differential metabolites was identified. Moreover, metabolite set enrichment analysis of these potential metabolic biomarkers revealed altered lipid metabolism in PA. In conclusion, our findings contribute to a better understanding of the metabolic changes in PA and may have implications for the development of diagnostic and therapeutic approaches targeting lipid metabolism in PA. We believe that the proposed strategy serves as a valuable tool for screening robust, discriminating metabolic features in the field of metabolomics.
- 28 February 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (12) , 4745-4755
Strategy for Identifying a Robust Metabolomic Signature Reveals the Altered Lipid Metabolism in Pituitary Adenoma
Despite the well-established connection between systematic metabolic abnormalities and the pathophysiology of pituitary adenoma (PA), current metabolomic studies have reported an extremely limited number of metabolites associated with PA. Moreover, there was very little consistency in the identified metabolite signatures, resulting in a lack of robust metabolic biomarkers for the diagnosis and treatment of PA. Herein, we performed a global untargeted plasma metabolomic profiling on PA and identified a highly robust metabolomic signature based on a strategy. Specifically, this strategy is unique in (1) integrating repeated random sampling and a consensus evaluation-based feature selection algorithm and (2) evaluating the consistency of metabolomic signatures among different sample groups. This strategy demonstrated superior robustness and stronger discriminative ability compared with that of other feature selection methods including Student's t-test, partial least-squares-discriminant analysis, support vector machine recursive feature elimination, and random forest recursive feature elimination. More importantly, a highly robust metabolomic signature comprising 45 PA-specific differential metabolites was identified. Moreover, metabolite set enrichment analysis of these potential metabolic biomarkers revealed altered lipid metabolism in PA. In conclusion, our findings contribute to a better understanding of the metabolic changes in PA and may have implications for the development of diagnostic and therapeutic approaches targeting lipid metabolism in PA. We believe that the proposed strategy serves as a valuable tool for screening robust, discriminating metabolic features in the field of metabolomics.
- 15 January 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (4) , 1410-1418
MultiClassMetabo: A Superior Classification Model Constructed Using Metabolic Markers in Multiclass Metabolomics
Multiclass metabolomics has become a popular technique for revealing the mechanisms underlying certain physiological processes, different tumor types, or different therapeutic responses. In multiclass metabolomics, it is highly important to uncover the underlying biological information on biosamples by identifying the metabolic markers with the most associations and classifying the different sample classes. The classification problem of multiclass metabolomics is more difficult than that of the binary problem. To date, various methods exist for constructing classification models and identifying metabolic markers consisting of well-established techniques and newly emerging machine learning algorithms. However, how to construct a superior classification model using these methods remains unclear for a given multiclass metabolomic data set. Herein, MultiClassMetabo has been developed for constructing a superior classification model using metabolic markers identified in multiclass metabolomics. MultiClassMetabo can enable online services, including (a) identifying metabolic markers by marker identification methods, (b) constructing classification models by classification methods, and (c) performing a comprehensive assessment from multiple perspectives to construct a superior classification model for multiclass metabolomics. In summary, MultiClassMetabo is distinguished for its capability to construct a superior classification model using the most appropriate method through a comprehensive assessment, which makes it an important complement to other available tools in multiclass metabolomics. MultiClassMetabo can be accessed at http://idrblab.cn/multiclassmetabo/.
- 15 January 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (4) , 1410-1418
MultiClassMetabo: A Superior Classification Model Constructed Using Metabolic Markers in Multiclass Metabolomics
Multiclass metabolomics has become a popular technique for revealing the mechanisms underlying certain physiological processes, different tumor types, or different therapeutic responses. In multiclass metabolomics, it is highly important to uncover the underlying biological information on biosamples by identifying the metabolic markers with the most associations and classifying the different sample classes. The classification problem of multiclass metabolomics is more difficult than that of the binary problem. To date, various methods exist for constructing classification models and identifying metabolic markers consisting of well-established techniques and newly emerging machine learning algorithms. However, how to construct a superior classification model using these methods remains unclear for a given multiclass metabolomic data set. Herein, MultiClassMetabo has been developed for constructing a superior classification model using metabolic markers identified in multiclass metabolomics. MultiClassMetabo can enable online services, including (a) identifying metabolic markers by marker identification methods, (b) constructing classification models by classification methods, and (c) performing a comprehensive assessment from multiple perspectives to construct a superior classification model for multiclass metabolomics. In summary, MultiClassMetabo is distinguished for its capability to construct a superior classification model using the most appropriate method through a comprehensive assessment, which makes it an important complement to other available tools in multiclass metabolomics. MultiClassMetabo can be accessed at http://idrblab.cn/multiclassmetabo/.
- 11 December 2023
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 63 (24) , 7628-7641
Evaluating Machine Learning Methods of Analyzing Multiclass Metabolomics
Multiclass metabolomic studies have become popular for revealing the differences in multiple stages of complex diseases, various lifestyles, or the effects of specific treatments. In multiclass metabolomics, there are multiple data manipulation steps for analyzing raw data, which consist of data filtering, the imputation of missing values, data normalization, marker identification, sample separation, classification, and so on. In each step, several to dozens of machine learning methods can be chosen for the given data set, with potentially hundreds or thousands of method combinations in the whole data processing chain. Therefore, a clear understanding of these machine learning methods is helpful for selecting an appropriate method combination for obtaining stable and reliable analytical results of specific data. However, there has rarely been an overall introduction or evaluation of these methods based on multiclass metabolomic data. Herein, detailed descriptions of these machine learning methods in multiple data manipulation steps are reviewed. Moreover, an assessment of these methods was performed using a benchmark data set for multiclass metabolomics. First, 12 imputation methods for imputing missing values were evaluated based on the PSS (Procrustes statistical shape analysis) and NRMSE (normalized root-mean-square error) values. Second, 17 normalization methods for processing multiclass metabolomic data were evaluated by applying the PMAD (pooled median absolute deviation) value. Third, different methods of identifying markers of multiclass metabolomics were evaluated based on the CWrel (relative weighted consistency) value. Fourth, nine classification methods for constructing multiclass models were assessed using the AUC (area under the curve) value. Performance evaluations of machine learning methods are highly recommended to select the most appropriate method combination before performing the final analysis of the given data. Overall, detailed descriptions and evaluation of various machine learning methods are expected to improve analyses of multiclass metabolomic data.
- 11 December 2023
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 63 (24) , 7628-7641
Evaluating Machine Learning Methods of Analyzing Multiclass Metabolomics
Multiclass metabolomic studies have become popular for revealing the differences in multiple stages of complex diseases, various lifestyles, or the effects of specific treatments. In multiclass metabolomics, there are multiple data manipulation steps for analyzing raw data, which consist of data filtering, the imputation of missing values, data normalization, marker identification, sample separation, classification, and so on. In each step, several to dozens of machine learning methods can be chosen for the given data set, with potentially hundreds or thousands of method combinations in the whole data processing chain. Therefore, a clear understanding of these machine learning methods is helpful for selecting an appropriate method combination for obtaining stable and reliable analytical results of specific data. However, there has rarely been an overall introduction or evaluation of these methods based on multiclass metabolomic data. Herein, detailed descriptions of these machine learning methods in multiple data manipulation steps are reviewed. Moreover, an assessment of these methods was performed using a benchmark data set for multiclass metabolomics. First, 12 imputation methods for imputing missing values were evaluated based on the PSS (Procrustes statistical shape analysis) and NRMSE (normalized root-mean-square error) values. Second, 17 normalization methods for processing multiclass metabolomic data were evaluated by applying the PMAD (pooled median absolute deviation) value. Third, different methods of identifying markers of multiclass metabolomics were evaluated based on the CWrel (relative weighted consistency) value. Fourth, nine classification methods for constructing multiclass models were assessed using the AUC (area under the curve) value. Performance evaluations of machine learning methods are highly recommended to select the most appropriate method combination before performing the final analysis of the given data. Overall, detailed descriptions and evaluation of various machine learning methods are expected to improve analyses of multiclass metabolomic data.
- Open Access
- 19 October 2023
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (D1) , D859-D870
CellSTAR: a comprehensive resource for single-cell transcriptomic annotation
Large-scale studies of single-cell sequencing and biological experiments have successfully revealed expression patterns that distinguish different cell types in tissues, emphasizing the importance of studying cellular heterogeneity and accurately annotating cell types. Analysis of gene expression profiles in these experiments provides two essential types of data for cell type annotation: annotated references and canonical markers. In this study, the first comprehensive database of single-cell transcriptomic annotation resource (CellSTAR) was thus developed. It is unique in (a) offering the comprehensive expertly annotated reference data for annotating hundreds of cell types for the first time and (b) enabling the collective consideration of reference data and marker genes by incorporating tens of thousands of markers. Given its unique features, CellSTAR is expected to attract broad research interests from the technological innovations in single-cell transcriptomics, the studies of cellular heterogeneity & dynamics, and so on. It is now publicly accessible without any login requirement at: https://idrblab.org/cellstar.
- 19 October 2023
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (D1) , D859-D870
Open AccessCellSTAR: a comprehensive resource for single-cell transcriptomic annotation
Large-scale studies of single-cell sequencing and biological experiments have successfully revealed expression patterns that distinguish different cell types in tissues, emphasizing the importance of studying cellular heterogeneity and accurately annotating cell types. Analysis of gene expression profiles in these experiments provides two essential types of data for cell type annotation: annotated references and canonical markers. In this study, the first comprehensive database of single-cell transcriptomic annotation resource (CellSTAR) was thus developed. It is unique in (a) offering the comprehensive expertly annotated reference data for annotating hundreds of cell types for the first time and (b) enabling the collective consideration of reference data and marker genes by incorporating tens of thousands of markers. Given its unique features, CellSTAR is expected to attract broad research interests from the technological innovations in single-cell transcriptomics, the studies of cellular heterogeneity & dynamics, and so on. It is now publicly accessible without any login requirement at: https://idrblab.org/cellstar.
- 21 March 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 95 (13) , 5542-5552
Critical Assessment of the Biomarker Discovery and Classification Methods for Multiclass Metabolomics
Multiclass metabolomics has been widely applied in clinical practice to understand pathophysiological processes involved in disease progression and diagnostic biomarkers of various disorders. In contrast to the binary problem, the multiclass classification problem is more difficult in terms of obtaining reliable and stable results due to the increase in the complexity of determining exact class decision boundaries. In particular, methods of biomarker discovery and classification have a significant effect on the multiclass model because different methods with significantly varied theories produce conflicting results even for the same dataset. However, a systematic assessment for selecting the most appropriate methods of biomarker discovery and classification for multiclass metabolomics is still lacking. Therefore, a comprehensive assessment is essential to measure the suitability of methods in multiclass classification models from multiple perspectives. In this study, five biomarker discovery methods and nine classification methods were assessed based on four benchmark datasets of multiclass metabolomics. The performance assessment of the biomarker discovery and classification methods was performed using three evaluation criteria: assessment a (cluster analysis of sample grouping), assessment b (biomarker consistency in multiple subgroups), and assessment c (accuracy in the classification model). As a result, 13 combining strategies with superior performance were selected under multiple criteria based on these benchmark datasets. In conclusion, superior strategies that performed consistently well are suggested for the discovery of biomarkers and the construction of a classification model for multiclass metabolomics.
- 21 March 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 95 (13) , 5542-5552
Critical Assessment of the Biomarker Discovery and Classification Methods for Multiclass Metabolomics
Multiclass metabolomics has been widely applied in clinical practice to understand pathophysiological processes involved in disease progression and diagnostic biomarkers of various disorders. In contrast to the binary problem, the multiclass classification problem is more difficult in terms of obtaining reliable and stable results due to the increase in the complexity of determining exact class decision boundaries. In particular, methods of biomarker discovery and classification have a significant effect on the multiclass model because different methods with significantly varied theories produce conflicting results even for the same dataset. However, a systematic assessment for selecting the most appropriate methods of biomarker discovery and classification for multiclass metabolomics is still lacking. Therefore, a comprehensive assessment is essential to measure the suitability of methods in multiclass classification models from multiple perspectives. In this study, five biomarker discovery methods and nine classification methods were assessed based on four benchmark datasets of multiclass metabolomics. The performance assessment of the biomarker discovery and classification methods was performed using three evaluation criteria: assessment a (cluster analysis of sample grouping), assessment b (biomarker consistency in multiple subgroups), and assessment c (accuracy in the classification model). As a result, 13 combining strategies with superior performance were selected under multiple criteria based on these benchmark datasets. In conclusion, superior strategies that performed consistently well are suggested for the discovery of biomarkers and the construction of a classification model for multiclass metabolomics.